CDSCO monthly lab alert
CDSCO NSQ alert, October 2024: 93 drug batches flagged
By Blacklisted editorial team· Published 20 Nov 2024· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its October 2024 alert, the Central Drugs Standard Control Organisation listed 93 drug batches that failed quality tests, 56 at central laboratories and 37 at state drug-testing laboratories, from 72 manufacturers across 76 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Vitamin B Complex Tablet, SUCRALFATE USP, Itraconazole Capsules USP 100 mg.
93
Batches flagged
56 / 37
Central / state labs
Assay
Top reason
72
Manufacturers
Batches per month, last 12 alerts
Nov 2023Oct 2024 · 93
Full list of NSQ batches, October 2024
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| cefixime Dispersible Tablets IP 100mg | Batch CT240783Mfg Jul 2024 · Exp Jun 2026 | Theon Pharmaceuticals LtdHimachal Pradesh | Assay & DisintegrationAssay | SDTL Agartala, TripuraState lab |
| Zyfer-XT Tablets, Ferrous Ascorbate, Folic Acid Tablets | Batch WW-2405Mfg May 2024 · Exp Oct 2025 | Hindustan Nutraceuticals INCTelangana | NOT OF STANDARD QUALITY Sample Does not meets the Specifications wrt. Assay of Folic Acid as per STP.Assay | State Lab Drugs Control Laboratory, TelanganaState lab |
| Vitamin B m plex Tablets N.F.I | Batch VBT2442Mfg Apr 2024 · Exp Mar 2026 | Modern LaboratoriesMadhya Pradesh | DescriptionDescription | SDTL Agartala, TripuraState lab |
| Vitamin B Complex Tablets N.F.I | Batch VBT2498Mfg Jun 2024 · Exp May 2026 | Modern LaboratoriesMadhya Pradesh | DescriptionDescription | SDTL Agartala, TripuraState lab |
| Vitamin B Complex Tablet | Batch S0010/24- 25Mfg ? · Exp ? | Supplied by Kerala Medical Services Corporation LtdKerala | The sample does not conform to IP Standards with respect to ?Descriptive part? for tabletsOther | DTL ThiruvananthapuramState lab |
| Vitamin B Complex Tablet | Batch S0008/24- 25Mfg ? · Exp ? | Supplied by Kerala Medical Services Corporation LtdKerala | The sample does not conform to IP Standards with respect to ?Descriptive part? for tabletsOther | DTL ThiruvananthapuramState lab |
| Vitamin B Complex Tablet | Batch S0009/24- 25Mfg ? · Exp ? | Supplied by Kerala Medical Services Corporation LtdKerala | The sample does not conform to IP Standards with respect to ?Descriptive part? for tabletsOther | DTL ThiruvananthapuramState lab |
| VRIZAROX-100DT Tablets Cefpodoxime Proxetil Dispersible Tablets | Batch CABQ4001Mfg Jan 2024 · Exp Dec 2025 | Chiros PharmaHimachal Pradesh | MISBRANDED The monograph of Cefpodoxime Tablets in the current edition of Indian Pharamacopoeia i.e. IP-2022. is also applicable for Cefpodoxime Dispersible Tablets as indicated under labelling section of the monograph. However the firm failed to indicate the latters IP after the product name CefpodoximeDispersible Tablets. Hence, the drug is deemed to be Misbranded as per section 17 of the Drugs and Cosmetics Act, 1940, since it is not labeled in the prescribed mannar.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Trypsin & Chymotrypsin Tablets (Lysoflam Forte) | Batch LFTF24002CMfg Jun 2024 · Exp May 2026 | Cachet Pharmaceuticals Pvt. LtdHimachal Pradesh | Assay of Trypsin & ChymotrypsinAssay | CDL KolkataCDSCO lab |
| Trenaxa Inj. [Tranexamic Acid injection I.P] | Batch TNA2407Mfg Mar 2024 · Exp Feb 2026 | Sanjivani Paranteral LtdMaharashtra | It fails the test Sterility as per IPSterility | DTL ThiruvananthapuramState lab |
| Torsemide Tablets IP (Torverge-10 Tablets) | Batch GT7137AMfg Mar 2023 · Exp Feb 2025 | J.M. LaboratoriesHimachal Pradesh | Assay of Torsemide (86.85%)Assay | RDTL ChandigarhState lab |
| Theophylline & Etophylline Tablets | Batch TE4029Mfg Apr 2024 · Exp Mar 2027 | Kerala State Drugs and Pharmaceuticals LtdKerala | It fails the test ?Disintegration? Specified in the Laboratory Protocol as per IPDisintegration | DTL ThiruvananthapuramState lab |
| Terbinafine Hydrochloride Tablets IP (TERBONATE- 250) | Batch NT-7900Mfg Mar 2024 · Exp Feb 2026 | Neptune Life Sciences Pvt. LtdHimachal Pradesh | Test for DissolutionDissolution | CDTL HyderabadCDSCO lab |
| Telmisartan Tablets IP 40 mg | Batch LMT240536Mfg May 2024 · Exp Apr 2026 | Life Max Cancer Laboratories | DescriptionDescription | RDTL GuwahatiCDSCO lab |
| Telmisartan Tablets I.P. 40 mg | Batch LMT240611Mfg May 2024 · Exp Apr 2026 | Life Max Cancer Laboratories | DescriptionDescription | RDTL GuwahatiCDSCO lab |
| Telmisartan Tablets I.P. (Telesky-40 Tablet) | Batch CMT23-1658Mfg Mar 2024 · Exp Feb 2026 | Cortex Medical IncHimachal Pradesh | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Telmisartan Tab IP 40 mg | Batch S0007/24- 25Mfg ? · Exp ? | Supplied by Kerala Medical Services Corporation LtdKerala | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab |
| Tablets, Divalproex Sodium SR Tablets 500 mg | Batch TMT-0211Mfg Jun 2024 · Exp May 2026 | Tas Med (India) Pvt.ltdHimachal Pradesh | MISBRANDED The drug product Divalproex Sodium SR Tablets is official in the currect edition of IP 2022. and as required as per second schedule of the Drugs and cosmetics Act, 1940, the said drug product shall comply with the standards set out in the Indian Pharmacopoeia. But the designation IP in conjunctin with the official title Divalproex Sodium SR Tablets on the label of the drug product was not mentioned as an indication that the drug product purports to comply with IP standrds. Hence the drug product shall be deemed to be MISBRANDED DRUG as per Section 17 of the drug and Cosmetics Act 1940 as it not labeled in the prescribed mannerMisbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Tablets, Cefixime Tablets IP 400 mg | Batch CTTB-01Mfg Jun 2024 · Exp May 2026 | Nestor Pharmaceticals Limited 11Haryana | NOT OF STANDARD QUALITY Tablets does not complies in respect of Description.Description | State Lab Drugs Control Laboratory, TelanganaState lab |
| Sodium Fusidate Cream 2 % | Batch 344Mfg Nov 2023 · Exp Oct 2025 | Bharat Parenterals LtdGujarat | AssayAssay | CDTL MumbaiCDSCO lab |
| Single use Syringe (EDGEX) | Batch 5DSB27Mfg Nov 2023 · Exp Oct 2028 | Noble Pharmacare LtdOdisha | Cleanliness and Design of Piston/Plunger assemblyOther | RDTL ChandigarhCDSCO lab |
| SUCRALFATE USP | Batch LSU2404015Mfg Apr 2024 · Exp Mar 2029 | Legend IndustriesGujarat | Spurious, Identification & AssayAssay | CDL KolkataCDSCO lab |
| SUCRALFATE USP | Batch SCF/24/0049Mfg May 2024 · Exp Apr 2029 | Par Drugs & Chemicals LimitedGujarat | Spurious, Identification & AssayAssay | CDL KolkataCDSCO lab |
| Rosuvastatin Tablets IP (Rosuvas 10) | Batch SIE0116AMfg Feb 2023 · Exp Jul 2025 | Under Investigation | Dissolution and AssayAssay | Not applicableState lab |
| Rosuvastatin Tablets IP (ROZUTIN- 10) | Batch VDT-23531Mfg Jun 2023 · Exp May 2025 | Vidhyasha PharmaceuticalsHimachal Pradesh | Related SubstancesRelated substances | CDL KolkataCDSCO lab |
| Racecadotril & Oflozacin Suspension (Combact-O + Suspension) | Batch L23J003AMfg Oct 2023 · Exp Sep 2025 | Bajaj FormulationsUttarakhand | Assay of Racecadotril & OfloxacinAssay | CDTL MumbaiCDSCO lab |
| Rabeprazole Sodium (Enteric Coated) And Domperidone (Sustained Release) Capsules (ZABIL- DSR) | Batch UD2C- 23469EMfg Jun 2023 · Exp May 2025 | Ultra Drugs Pvt. LtdHimachal Pradesh | Dissolution of Rabeprazole & Domperidone, Assay of DomperidoneAssay | CDL KolkataCDSCO lab |
| Rabeprazole Sodium (EC) and Levosulpiride (SR) Capsules (RPL LS CAPSULES) | Batch CGC-24020Mfg Aug 2024 · Exp Jul 2026 | Calrax Healthcare Pvt.LtdHimachal Pradesh | Dissolution of LevosulpirideDissolution | RDTL ChandigarhCDSCO lab |
| Rabeprazole Sodium & Domperidone SR Capsules (RABALKEM- DSR) | Batch RKBC22064 SMfg Dec 2022 · Exp Nov 2024 | Shiva Biogenetic Laboratories Pvt. LtdHimachal Pradesh | Assay of RabeprazoleAssay | CDL KolkataCDSCO lab |
| Propylene Glycol USP / IP | Batch BT1205B251 22023Mfg Dec 2023 · Exp Dec 2025 | Balaji Amines LimitedMaharashtra | WaterWater content | CDTL MumbaiCDSCO lab |
| Paracetamol Tablets IP 650 mg [Nopain-650] | Batch URDT2433Mfg Oct 2023 · Exp Sep 2026 | Unicure India LtdUttarakhand | It fails the test ?Dissolution? Specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab |
| Paracetamol Tablets IP 500 mg (Pararex-500 | Batch CT-7129Mfg Sep 2023 · Exp Aug 2026 | Chemetac Pharmaceuticals 42Uttar Pradesh | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Pantoprazole Tablets IP | Batch MT-23J13Mfg Oct 2023 · Exp Mar 2025 | Martin & Brown Bio- Sciences Pvt.LtdHimachal Pradesh | Dissolution (Buffer Stage)Dissolution | RDTL ChandigarhCDSCO lab |
| Pantoprazole Sodium (Enteric Coated and Domperidone (Sustained Release) Capsules (Penstal-DSR) | Batch C582Mfg Jan 2024 · Exp Dec 2025 | Stalion Laboratories Pvt. LtdGujarat | Dissolution of DomperidoneDissolution | CDTL MumbaiCDSCO lab |
| Pantoprazole Gastro-resistant and Domeperiodone Prolong Released Capsules IP (PAN-D) | Batch 23444296Mfg Dec 2023 · Exp Nov 2025 | Under Investigation | Identification and AssayAssay | Not applicableState lab |
| Panlib -D [Pantoprazole and Domeperidone Tablets] | Batch HTN253DMfg Apr 2024 · Exp Mar 2026 | Himalaya Meditek Pvt. LtdUttarakhand | It fails the test ?Disintegration? as per IP and the contents of active ingredients of Pantoprazole and Domeperidone are not with in the limits of ?Schedule V? of Drugs and Cosmetics Act & Rules thereunder as specified in the Laboratory ProtocolDisintegration | DTL ThiruvananthapuramState lab |
| Paclitaxel Injection IP | Batch OI220089AMfg Nov 2022 · Exp Oct 2024 | Cosmas Research Lab LtdPunjab | Description & Particulate MatterDescription | CDL KolkataCDSCO lab |
| Ornidazole & Ofloxacin Tablets IP | Batch HOOA07Mfg Aug 2023 · Exp Jul 2025 | Hindustan Antibiotics LtdHaryana | DescriptionDescription | CDL KolkataCDSCO lab |
| Ondansetron Injection IP 2mg/ml | Batch OT-5411Mfg Aug 2024 · Exp Jul 2026 | Alchemist Remedies Pvt. LtdMadhya Pradesh | The sample does not Conform to IP Standards with respect to TEST FOR STERILITYSterility | CDTL ChennaiCDSCO lab |
| Natamycin Ophthalmic Suspension IP (Nataprime Eye Drops) | Batch PE062308Mfg Jun 2023 · Exp May 2025 | Primus PharmaceuticalsHimachal Pradesh | SterilitySterility | CDL KolkataCDSCO lab |
| Myoplus Tablets, Paracetamol & Chlorzoxazone Tabletes | Batch MT24-1Mfg Apr 2024 · Exp Mar 2026 | Leostar Healthcare Pvt. LtdTelangana | NOT OF STANDARD QUALITY 18 Tablets were tested. All the 18 tablets did not Disintigrate within the time limit (i.e 15 Minutes) specified as per IP.Other | State Lab Drugs Control Laboratory, TelanganaState lab |
| Montelukast Tablets IP 10 mg | Batch F4E0425Mfg May 2024 · Exp Apr 2026 | Morepan Laboratories Ltd | It fails the test ?Dissolution? Specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab |
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP 10 mg/5 mg | Batch MLHT-1022Mfg Sep 2023 · Exp Aug 2026 | Wings Biotech LLPHimachal Pradesh | It fails the test ?Dissolution? Specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab |
| Metronidazole 400 mg Tablets (Metagyl - 400) | Batch B22-275Mfg Dec 2022 · Exp May 2025 | Saint Michael BiotechUttarakhand | Dissolution of Metronidazole.Dissolution | RDTL GuwahatiCDSCO lab |
| Meropenem Injection IP (ZENEM 1 g INJECTION) | Batch B240720DMfg Jul 2024 · Exp Jun 2026 | Oscar Remedies Pvt. Ltd | Particulate matter and Content of SodiumParticulate matter | RDTL ChandigarhCDSCO lab |
| Liposomal Amphotericinn B Injection 50mg (Ambilip) | Batch ALLC4A1Mfg Mar 2024 · Exp Feb 2026 | United Biotech (P) LimitedHimachal Pradesh | Bacterial endotoxins and Assay of Amphotericin BAssay | CDL KolkataCDSCO lab |
| Itraconazole Capsules USP 100 mg | Batch IZC2401Mfg Apr 2024 · Exp Mar 2026 | Modern LaboratoriesMadhya Pradesh | DissolutionDissolution | SDTL Agartala, TripuraState lab |
| Itraconazole Capsules USP 100 mg | Batch IZC2401Mfg Apr 2024 · Exp Mar 2026 | Modern LaboratoriesMadhya Pradesh | DissolutionDissolution | SDTL Agartala, TripuraState lab |
| Iron Sucrose Injection USP 5 ml | Batch IRA12320Mfg Aug 2023 · Exp Jul 2025 | Nandani Medical Laboratories Pvt. LtdMadhya Pradesh | Specific Gravity, Particulate matter, Assay of Sucrose & Assay of Ferric Hydroxide with sucrose calculated as elemental IronAssay | CDL KolkataCDSCO lab |
| Iron Sucrose Injection USP 5 ml | Batch MA24B129Mfg Feb 2024 · Exp Jan 2026 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | Particulate MatterParticulate matter | CDL KolkataCDSCO lab |
| International dona Beauty Soap Jasmine | Batch DNJN1/24Mfg Jan 2024 · Exp Jan 2027 | Excel+ Health care products | The sample does not conform to IS 2888:2004 for the test ?matter insoluble in alcohol, percent by Mass, Max ? as per the specifications of toilet soap for Grade IIIOther | DTL ThiruvananthapuramState lab |
| Hydroquinone, Tretinoin & Allantoin Cream (Lumadip) | Batch LD-18Mfg Dec 2023 · Exp Nov 2025 | Tosc International Pvt. LtdUttarakhand | Description & pHDescription | CDL KolkataCDSCO lab |
| Glucosamine Sulfate Potassium Chloride MSM and Diacerein Tablets (Orcerin GM) | Batch KOO2207AMfg May 2022 · Exp Apr 2025 | Macleods Pharmaceuticals LtdSikkim | DescriptionDescription | CDL KolkataCDSCO lab |
| Glimepiride Tablets IP 2 mg | Batch LMT240333Mfg Mar 2024 · Exp Feb 2026 | Life Max Cancer LaboratoriesUttarakhand | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Fexofenadine Hydrochloride Tablets I.P. | Batch T-2403971Mfg Mar 2023 · Exp Feb 2026 | Oscar Remedies Pvt. Ltd | Dissolution of Fexofenadine Hydrochloride.Dissolution | RDTL GuwahatiCDSCO lab |
| Fer-XT Tablets, Ferrous Ascorbate & Folic Acid Tablets | Batch FXT.2309Mfg Sep 2023 · Exp Feb 2025 | Alfansa Bio Pvt.LtdTelangana | NOT OF STANDARD QUALITY & MISBRANDED The drug product ferrous Ascorbate and Folic Acid Tables is official in Indian Pharamacopoeia 2022. But the letters IP is not mentioned on the strip after the product name Ferrous Ascorbate and Folic Acid tablets. Hence it is a Misbranded Drug under section 17 of Drugs and Cosmetics Act 1940. So the drug product Ferrous Ascorbate & Folic Acid Tablets is Not of Standard Quality and Misbranded.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Esomeprazole Tablets IP 40 mg (Essokynt-40) | Batch TT23-505Mfg Jul 2023 · Exp Jun 2025 | Tanishka Pharmaceuticals Pvt. LtdHimachal Pradesh | Dissolution (Buffer Stage)Dissolution | RDTL GuwahatiCDSCO lab |
| Enrofloxacin Injection I.P. (Vet.) (ENROXACIN VET Injection) | Batch LV326Mfg Jan 2023 · Exp Dec 2024 | Lavista Ideal Pharmacy Pvt. LtdHimachal Pradesh | pHpH | CDL KolkataCDSCO lab |
| Enalapril Maleate Tablets IP 5 mg (Opioril- 5) | Batch 23HT1771Mfg Nov 2023 · Exp Oct 2025 | Orison Pharma InternationalHimachal Pradesh | Dissolution and Assay of Enalapril MaleateAssay | CDTL MumbaiCDSCO lab |
| Elcipro 500[Ciprofloxacin Hydrochloride Tab IP 500 mg ] | Batch AGT31256Mfg Dec 2023 · Exp Dec 2023 | Alventa Pharma LtdHimachal Pradesh | It fails the test ?Dissolution? as per IP as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab |
| EMITIL [Prochlorperazine Mesylate Injection IP] | Batch MA 24E27Mfg May 2024 · Exp Apr 2026 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | It fails the test ?pH? as per IP as specified in the Laboratory ProtocolpH | DTL ThiruvananthapuramState lab |
| Dulhan Special | Batch NilMfg ? · Exp ? | Mohsin Idustries | MISBRANDEDMisbranded | State Lab, Drugs ControlState lab |
| Divalproex Sodium SR Tablets 500 mg | Batch TMT-0164Mfg Jun 2024 · Exp May 2024 | Tas Med (India) Pvt.ltdHimachal Pradesh | MISBRANDED The drug product Divalproex Sodium SR Tablets is official in the currect edition of IP 2022. and as required as per second schedule of the Drugs and cosmetics Act, 1940, the said drug product shall comply with the standards set out in the Indian Pharmacopoeia. But the designation IP in conjunctin with the official title Divalproex Sodium SR Tablets on the label of the drug product was not mentioned as an indication that the drug product purports to comply with IP standrds. Hence the drug product shall be deemed to be MISBRANDED DRUG as per Section 17 of the drug and Cosmetics Act 1940 as it not labeled in the prescribed mannerMisbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Divalproex Sodium SR Tablets | Batch TMT-0165Mfg Jun 2024 · Exp May 2024 | Tas Med (India) Pvt.ltdHimachal Pradesh | MISBRANDED The drug product Divalproex Sodium SR Tablets is official in the currect edition of IP 2022. and as required as per second schedule of the Drugs and cosmetics Act, 1940, the said drug product shall comply with the standards set out in theMisbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Diclofenac Sodium, Paracetamol & Chlorzoxazone Tablets | Batch DCPT3310Mfg Sep 2023 · Exp Aug 2025 | Modern LaboratoriesMadhya Pradesh | DisintegrationDisintegration | CDL KolkataCDSCO lab |
| Decitabine for Injection 50 mg / vial | Batch H230266Mfg Mar 2023 · Exp Feb 2025 | Dr. Reddys LaboratoriesAndhra Pradesh | Water ContentWater content | CDL KolkataCDSCO lab |
| Ciprofloxcin Tablets IP 250 mg | Batch CT23241818Mfg Feb 2024 · Exp Jan 2026 | CMG Biotech Pvt. Ltd | Dissolution of CiprofloxcinDissolution | RDTL GuwahatiCDSCO lab |
| Ciprofloxacin Tablets U.S.P. 500 mg | Batch T-2401066Mfg Jan 2024 · Exp Dec 2025 | Rivpra Formulation Pvt. LtdUttarakhand | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Ciprofloxacin Injection IP 100 ml | Batch 09AF0061Mfg Dec 2022 · Exp Nov 2025 | Paschim Banga Pharmaceuticals | Extractable VolumeExtractable volume | CDL KolkataCDSCO lab |
| Chlorhexidine Gluconate Solution 4% w/v | Batch 12Mfg Jul 2024 · Exp Jun 2026 | Overseas Chemicals | AssayAssay | CDL KolkataCDSCO lab |
| Ceftriaxone and Sulbactam for Injection (Tykone- S Injection) | Batch UNI-240013Mfg Jun 2024 · Exp May 2027 | Unital FormulationsHimachal Pradesh | Particulate matterParticulate matter | RDTL ChandigarhCDSCO lab |
| Cefixime Tablets IP (TAXIM-O 200) | Batch 23460072Mfg Jan 2023 · Exp Dec 2024 | Under Investigation | Dissolution and AssayAssay | Not applicableState lab |
| Cefem -200 Tablets, Cefixime with Lactic Acid Bacillus tablets | Batch DB240126Mfg Apr 2024 · Exp Mar 2026 | Daxin Pharmaceuticals Pvt. LtdHimachal Pradesh | NOT OF STANDARD QUALITY 1. Thirteen Individual weights deviated from the average weight 636.0 mg i.e 6 tablets deviated by less than 5 percent and 7 tablets deviated by more than 5 percent. Hence the sample does not complies the test Uniformity of weight. 2. Assay of Cefixime does not complies. Hence the sample is of NOT OF STANDARD QUALITYAssay | State Lab Drugs Control Laboratory, TelanganaState lab |
| Calcium 500 mg with Vitamin D3 250 IU Tablets IP | Batch LMT240377Mfg Mar 2024 · Exp Feb 2026 | Life Max Cancer LaboratoriesUttarakhand | Dissolution of Calcium and Assay of Vitamin D3Assay | RDTL GuwahatiCDSCO lab |
| CYPROHEPTAD INE HCl & TRICHOLINE CITRATE | Batch WHL-00623Mfg Feb 2024 · Exp Jan 2026 | Warner Hindusthan Pvt. LtdTelangana | The label of the container in the drug is mentioned as 'Approved colour used' but the common name of theLabelling | State Lab PuducherryState lab |
| C Mont LC KID 60 ml[Montelukast and Levocetirizine Dihydrochloride syrup 60 ml ] | Batch AL 23206Mfg Nov 2023 · Exp Oct 2025 | Cian Healthcare LtdUttarakhand | The content of Montelukast sodium is not with in the limits of ?Schedule V? of Drugs and Cosmetics Act & Rules thereunder as specified in the Laboratory ProtocolOther | DTL ThiruvananthapuramState lab |
| Bupropion Hydrochloride Extended Release Tablets U.S.P. 150 mg (Brudel SR-150) | Batch T23169Mfg Sep 2023 · Exp Aug 2026 | Rebase Lifescience Pvt. LtdGujarat | Assay of Bupropion HydrochlorideAssay | CDTL MumbaiCDSCO lab |
| Buprenorphine Injection I.P. (LUPIGESIC) | Batch 1470 ASGMfg Jan 2024 · Exp Dec 2025 | S.M.G. PHARMACEUTICALS (Pvt) LtdGujarat | Assay" of BuprenorphineAssay | RDTL GuwahatiCDSCO lab |
| Buprenorphine Injection I.P. (LUPIGESIC) | Batch 1470 ASGMfg Sep 2023 · Exp Aug 2025 | S.M.G. PHARMACEUTICALS (Pvt) Ltd | Assay/Content of BuprenorphineAssay | RDTL GuwahatiCDSCO lab |
| Biocetamol -500 | Batch SPD230078Mfg Mar 2023 · Exp Feb 2025 | Mfg. By : Skymap Pharmaceuticals Pvt. LtdGujarat | The sample does not conform to the IP requirements with respect to the test, Dissolution.Dissolution | Drug Testing Laboratory Srinagar (J&K) vide report on Form 13 bearing No. L/DA/2024-25/1593 Dated: 29.10.2024. (Report attached as Annexure A)State lab |
| Betamethasone Sodium Phosphate Injection I.P. (Betalone) | Batch IBT-11189Mfg Jun 2024 · Exp May 2026 | E.G.PharmaceuticalsHimachal Pradesh | Description & Particulate matterDescription | CDL KolkataCDSCO lab |
| BETAHISTINE DIHYDROCHLO RIDE TABLETS IP(CGHEST-8) | Batch CT2425028 4BMfg Mar 2024 · Exp Apr 2026 | CMG Biotech Pvt. LtdHimachal Pradesh | On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discolouration-NSQDescription | State Lab PuducherryState lab |
| Ampicillin 1G Powder for Injection 1000 mg | Batch EXPN-24004Mfg Apr 2024 · Exp Mar 2026 | Unital FormulationsHimachal Pradesh | Particulate matter and Assay of Ampicillin Sodium calculated as AmpicillinAssay | RDTL ChandigarhCDSCO lab |
| Amoxycillin and Potassium Clavulanate for Injection IP 1.2 gm | Batch 23AP10Mfg Oct 2023 · Exp Sep 2025 | SAI Parenterals LimitedTelangana | Particulate matter & Clarity of SolutionParticulate matter | CDL KolkataCDSCO lab |
| Amoxycillin and Potassium Clavulanate Tablets IP (Moxileb-CV 625 Tablets) | Batch MBT23068Mfg Oct 2023 · Exp Sep 2025 | Mediwell BiotechHimachal Pradesh | Assay of Amoxycillin Trihydrate calculated as AmoxycillinAssay | RDTL ChandigarhCDSCO lab |
| Amoxycillin and Potassium Clavulanate Injection (Manclav 300 mg) | Batch HIAP23001AMfg Jan 2023 · Exp Dec 2024 | Health Biotech LtdHimachal Pradesh | Particulate matter and Assay of Potassium Clavulanate calculated as Clavulanic AcidAssay | RDTL ChandigarhCDSCO lab |
| Amlodipine and Perindopril Tablets (Amtas PRP) | Batch K2201310Mfg Jun 2022 · Exp May 2025 | Intas Pharmaceuticals LtdSikkim | Assay of Perindopril ErbumineAssay | CDL KolkataCDSCO lab |
| Adrenaline Injection IP 1.8mg/ml (Adrenascot) | Batch GA3A020Mfg Jan 2023 · Exp Dec 2024 | Scott-Edil Pharmacia LtdHimachal Pradesh | Appearance of Solution and DescriptionDescription | RDTL GuwahatiCDSCO lab |
| Aciclovir Intravenous Infusion IP 250 mg (Acyclotech Injection) | Batch D0072406BMfg Jun 2024 · Exp May 2026 | Protech TelelinksHimachal Pradesh | Assay of AciclovirAssay | RDTL ChandigarhCDSCO lab |
| Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Megaceclo SP) | Batch AMT2302037Mfg Feb 2023 · Exp Jan 2025 | Marine Medicare Pvt. LtdHimachal Pradesh | Description and Assay of SerratiopeptidaseAssay | CDL KolkataCDSCO lab |
| Aceclofenac & Paracetamol Tablets (Eldigesic-P) | Batch AGT305144Mfg May 2023 · Exp Apr 2026 | Alventa Pharma LtdHimachal Pradesh | Assay of AceclofenacAssay | CDTL MumbaiCDSCO lab |
| Absorbent Cotton Wool IP | Batch 2013Mfg Feb 2024 · Exp Jan 2027 | Jind Surgicals 24-27Haryana | Surface active Substances, Sulphated ash, Fluorescence, Water Soluble SubstancesWater content | CDL KolkataCDSCO lab |
| (COUGH-DM Cough Syrup) | Batch SHL3037Mfg Nov 2023 · Exp Oct 2025 | Sunfine HealthcareHimachal Pradesh | Assay of Phenylephrine HydrochlorideAssay | RDTL ChandigarhState lab |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (93 rows). Revised CDSCO lists are diffed on each monthly rebuild.